Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.28, $0.09 better than the analyst estimate of $0.19. Revenue for the quarter came in at $419.4 million versus the consensus estimate of $390.44 million.

GUIDANCE:

Exelixis sees FY2022 revenue of $1.53-1.63 billion, versus the consensus of $1.59 billion.

For earnings history and earnings-related data on Exelixis (EXEL) click here.